Multifaceted Care Pathway for Chronic Pain After Total Knee Arthroplasty .
The STAR care pathway for patients with pain at 3 months after total knee replacement: a multicentre, pragmatic, randomised, controlled trial
Lancet Rheumatol. 2022 Jan 28;4(3): e188-e197.Three hundred and sixty-three patients undergoing primary total knee replacement were randomized to either receive a multifaceted care [Support and Treatment After Replacement (STAR)] pathway (n=242) or usual care (n=121) for the treatment of chronic pain 12 weeks post-operatively. All patients received usual post-operative care at their hospital, which included a follow-up at 8 weeks. Co-primary outcomes of interest included pain severity and pain interference, measured using the brief pain inventory (BPI) at 12-months follow-up. Secondary outcomes such as the Oxford Knee Score (OKS), Pain Catastrophizing Scale, Pain Solutions Questionnaires (PaSol), Douler Neuropathique 4 (DN-4), SF-12 Short Form Survey, and Hospital Anxiety and Depression Scale (HADS) were assessed. At 12-months the BPI severity and interference scores favoured the STAR care pathway. OKS scores were significantly in favour of the STAR care pathway group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics